Induced pluripotent stem cell therapy (Myogenica)

N/A

Report date: 2025/04/08 15:30:57

Base Information

Drug NameInduced pluripotent stem cell therapy (Myogenica)
Drug Alias NameMyoPAXonCD54+ allogeneic muscle progenitor cell
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMyogenica Inc
China Registration ClassN/A

Develop Information

Active CompaniesMyogenica IncMasonic Cancer Center, University Of Minnesota
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A